Search - tctmd.com

Displaying 241 - 259 of 259

Sort: Relevancy | Date

Presentation TCT 2013

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Presenter: Sachin Goel, Wael El-Mallah, Mobolaji Ige, Supriya Gupta, E Murat Tuzcu, Stephen Ellis, Samir Kapadia

January 31, 2013

Presentation TCT 2013

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

Presenter: Myung-Hyun Kim, Byeong-Keuk Kim

January 31, 2013

Presentation TCT 2012

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Presenter: Suhas Lele

October 25, 2012

Presentation TCT 2012

Evaluation and Treatment of In-Stent Restenosis

Presenter: Christoph Kaiser

October 25, 2012

Presentation TCT 2012

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Presenter: Ricardo Costa

October 24, 2012

Presentation TCT 2012

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

What Can Advanced Stent Imaging Tell Us About In-Stent Restenosis, Plaque Prolapse, and Design of Future Stents?

Presenter: Mark Wholey

October 22, 2012

Presentation TCT 2012

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Presenter: Eugenio Stabile

October 22, 2012

Presentation

Drug-eluting Balloon for Treatment of Superficial Femoral Artery In-stent Restenosis

Presenter: E. Stabile

October 04, 2012

Presentation GI2 2012

Drug-Eluting Balloon: Clinical Evidence for In-Stent Restenosis

Presenter: Marco V. Wainstein

April 12, 2012

Presentation GI2 2012

The Controversy: DES vs DEB for In-Stent Restenosis

Presenter: Pedro A. Lemos

April 11, 2012

Presentation GI2 2012

Focus on In-Stent Restenosis: Imaging to Guide the Best Treatment

Presenter: Jose Ribamar Costa

April 11, 2012

Presentation

Randomized Trial of Optimal Treatment Strategies for In-Stent Restenosis After DES Implantation

Presenter: H. Song

March 12, 2012

Presentation CTO 2012

Management and Outcomes for Left Main In-stent Restenosis

Presenter: Martin Leon

February 23, 2012

Presentation

Clinical Outcomes and Treatment After DES Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis (ISR)

Presenter: G. Maluenda

February 15, 2012

Presentation TCT 2012

Noninvasive Assessment of In-Stent Restenosis by High Definition Computed Tomography Coronary Angiography with New Gemstone Detector

Presenter: Hirotsugu Mihara

January 03, 2012

Presentation TCT 2012

Multicenter Clinical Trial with Everolimus-Eluting stent for the treatment of Bare-Metal in-stent restenosis. Immediate and long-term clinical and angiographic outcome

Presenter: Didier Carri?, Nicolas Delarche, Christophe Piot, Jacques Berland, Nicolas Meneveau, Laurent Benello, Antoine Py, Emmanuel Teiger, Laurent Leborgne, Gilles Bayet, Olivier Wittenberg

January 03, 2012

Presentation TCT 2012

Current Treatment and Outcome of Coronary In-Stent Restenosis – Report from the Swedish Angiography and Angioplasty Registry (SCAAR)

Presenter: Torsten Schwalm, J?rg Carlsson, Bo Lagerqvist, Stefan James

January 03, 2012

Presentation TCT 2012

Comparison of Virtual Histology and OCT in the Tissue Characterization of In-Stent Restenosis.

Presenter: Koichi Hanada, Akihiro Nakamura

January 03, 2012

Advertisement

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Evaluation and Treatment of In-Stent Restenosis

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

What Can Advanced Stent Imaging Tell Us About In-Stent Restenosis, Plaque Prolapse, and Design of Future Stents?

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Drug-eluting Balloon for Treatment of Superficial Femoral Artery In-stent Restenosis

Drug-Eluting Balloon: Clinical Evidence for In-Stent Restenosis

The Controversy: DES vs DEB for In-Stent Restenosis

Focus on In-Stent Restenosis: Imaging to Guide the Best Treatment

Randomized Trial of Optimal Treatment Strategies for In-Stent Restenosis After DES Implantation

Management and Outcomes for Left Main In-stent Restenosis

Clinical Outcomes and Treatment After DES Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis (ISR)

Noninvasive Assessment of In-Stent Restenosis by High Definition Computed Tomography Coronary Angiography with New Gemstone Detector

Multicenter Clinical Trial with Everolimus-Eluting stent for the treatment of Bare-Metal in-stent restenosis. Immediate and long-term clinical and angiographic outcome

Current Treatment and Outcome of Coronary In-Stent Restenosis – Report from the Swedish Angiography and Angioplasty Registry (SCAAR)

Comparison of Virtual Histology and OCT in the Tissue Characterization of In-Stent Restenosis.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content